✦ LIBER ✦

Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation

✍ Scribed by Yoko Ishida; Kiriko Terasako; Kumi Oshima; Kana Sakamoto; Masahiro Ashizawa; Miki Sato; Misato Kikuchi; Shun-ichi Kimura; Hideki Nakasone; Shinya Okuda; Shinichi Kako; Rie Yamazaki; Junji Nishida; Yoshinobu Kanda

Publisher: Carden Jennings Publishing
Year: 2010
Tongue: English
Weight: 328 KB
Volume: 92
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-010-0678-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second Allogeneic Hematopoietic Stem Cel

Second Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia Relapse After First Allogeneic Transplantation: Outcome of 16 Patients in a Single Institution

✍ Akira Tomonari; Tohru Iseki; Jun Ooi; Hitomi Nagayama; Hiroyuki Sato; Tsutomu Ta 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 94 KB

Twenty Years’ Experience in Allogeneic H

Twenty Years’ Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group

✍ Hiroatsu Iida; Hiroshi Sao; Kenjiro Kitaori; Seiichi Gotoh; Makoto Yazaki; Seiji 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 98 KB

Dasatinib-induced complete molecular res

Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion

✍ Anna Czyz; Krzysztof Lewandowski; Renata Kroll; Mieczysław Komarnicki 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 186 KB

Case of a patient with Philadelphia-chro

Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions

✍ Makoto Yoshimitsu; Hiroshi Fujiwara; Atsuo Ozaki; Heiichiro Hamada; Kakushi Mats 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 163 KB

Nilotinib and donor lymphocyte infusion

Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib

✍ Mario Tiribelli; Alessandra Sperotto; Anna Candoni; Erica Simeone; Silvia Buttig 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 223 KB

The extent of minimal residual disease r

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af